Department of Blood Transfusion, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, China.
Department of Radiotherapy, Ningbo Medical Center Lihuili Hospital, Ningbo University, Ningbo, China.
PLoS One. 2024 Jan 19;19(1):e0296917. doi: 10.1371/journal.pone.0296917. eCollection 2024.
Previous studies have reported that the susceptibility to coronavirus disease 2019 (COVID-19) is related to ABO blood group, but the relationship with Rh phenotype and MN blood group is unknown. China had adopted a strict control policy on COVID-19 until December 5, 2022, when local communities were liberalized. Therefore, we aimed to explore the correlation between ABO blood group, Rh phenotype, MN blood group and susceptibility to COVID-19 based on the time sequence of infection during the pandemic.
A total of 870 patients who were routinely hospitalized in Ningbo Medical Center Lihuili Hospital from March 1, 2023 to March 31, 2023 were randomly selected to enroll in this study. Patients were divided into susceptible group and non-susceptible group, according to the time of their previous infection. The demographics and clinical information of the enrolled participants were collected from electronic medical records. The association of ABO blood group, Rh phenotype and MN blood group with susceptibility to COVID-19 was analyzed.
A total of 650 cases (74.7%) had been infected with COVID-19, with 157 cases (18.0%) in the second week and 252 cases (29.0%) in the third week, reaching the peak of infection. Compared with the non-susceptible group, the susceptible group had no statistically significant differences in ABO blood group and Rh phenotype, but the proportion of N+ was higher (75.6% vs 68.9%, P = 0.030) and the proportion of MM was lower (24.4% vs 31.1%, P = 0.030). Consistent with this, ABO blood group and Rh phenotype were not significantly associated with susceptibility to COVID-19 (P>0.05), while N+ and MM were associated with susceptibility to COVID-19 (OR: 1.432, 95% confidence interval [CI]: 1.049, 1.954, P = 0.024; OR: 0.698, 95% CI: 0.512, 0.953, P = 0.024, respectively), after adjusting for age, sex, BMI, basic disease, and vaccination status in multivariate logistic regression analysis.
Our study showed that ABO blood group and Rh phenotype may not be related to the susceptibility to COVID-19, but MN blood group may be associated with the susceptibility to COVID-19.
先前的研究报告表明,冠状病毒病 2019(COVID-19)的易感性与 ABO 血型有关,但与 Rh 表型和 MN 血型的关系尚不清楚。中国在 2022 年 12 月 5 日之前对 COVID-19 采取了严格的控制政策,当时社区已经放宽。因此,我们旨在根据大流行期间感染的时间顺序,探索 ABO 血型、Rh 表型和 MN 血型与 COVID-19 易感性之间的相关性。
本研究共纳入 2023 年 3 月 1 日至 2023 年 3 月 31 日期间在宁波医疗中心李惠利医院常规住院的 870 例患者。根据先前感染的时间,将患者分为易感组和非易感组。从电子病历中收集入组参与者的人口统计学和临床信息。分析 ABO 血型、Rh 表型和 MN 血型与 COVID-19 易感性的关系。
共有 650 例(74.7%)患者感染了 COVID-19,其中第 2 周 157 例(18.0%),第 3 周 252 例(29.0%),达到感染高峰。与非易感组相比,易感组在 ABO 血型和 Rh 表型方面无统计学差异,但 N+比例较高(75.6%比 68.9%,P=0.030),MM 比例较低(24.4%比 31.1%,P=0.030)。同样,ABO 血型和 Rh 表型与 COVID-19 易感性无显著相关性(P>0.05),而 N+和 MM 与 COVID-19 易感性相关(OR:1.432,95%置信区间[CI]:1.049,1.954,P=0.024;OR:0.698,95%CI:0.512,0.953,P=0.024),在多变量逻辑回归分析中,调整年龄、性别、BMI、基础疾病和疫苗接种状态后。
我们的研究表明,ABO 血型和 Rh 表型可能与 COVID-19 的易感性无关,但 MN 血型可能与 COVID-19 的易感性有关。